- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
After inter-company dialogue, Ipsen’s Dysport messaging (‘a toxin with a long-lasting effect’) was held to imply an unsubstantiated duration advantage. Appeal Board…
An employee complaint upheld after Accord’s public LinkedIn post referred positively to three prescription-only medicines as “vital COVID-19 medicines”, amounting to promotion…
Pulse Daily email linked to a sponsored ‘education hub’ that the Panel said promoted Gaviscon for prescription. Breaches included disguised promotion, unclear…
Anonymous complainant alleged Colonis’ public website promoted prescription-only medicines. Panel found the pages were non-promotional reference information with no product claims; no…
A Reletrans (buprenorphine) journal cover outsert became visible when ~3,300 copies were mailed in transparent polywrap. PMCPA ruled promotion of a POM…
After giving an undertaking to stop using misleading Meriofert vs Menopur claims, Pharmasure left similar claims live on its UK website. PMCPA…
Complaint about Sunosi website links, mobile prescribing info and dosing claim. Panel found no breach for external-link clarity or dosing claim, but…
Complaint alleged a Seretide Evohaler banner claim was misleading on age/indication and that “PI” was unclear. PMCPA ruled no breach across all…
Complaint about 60 videos on LEO’s Global YouTube. Most out of UK Code scope, but breaches found for an HCP symposium video…
Complaint about transparency of GSK sponsorship of a GP Online article and alleged disguised promotion on a low-carbon inhalers HCP website. Panel…
A gated UK HCP “educational” site hosted an article indirectly promoting Abilify Maintena, including off-label depression messaging and missing mandatory info. PMCPA…
Complaint about two Lixiana (edoxaban) websites. Most allegations not proven, but two webpage elements were ruled misleading: “lactose not listed as an…
A senior UK employee ‘liked’ LinkedIn posts about investigational/US-approved medicines and a Botox post. PMCPA ruled pre-licence promotion and public promotion of…
Complaint alleged Symbicort cost-calculator webpage lacked prescribing information and generic name and breached a prior undertaking. Panel and Appeal Board found the…
Lilly’s ‘Barber’s Box’ slide deck comparing GLP‑1RAs was ruled misleading: shaded comparative boxes and selective CVOT subgroup messaging implied advantages without adequate…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.